Farshid Guilak, MD

Professor, Orthopaedic Surgery, Washington University; Director of Research, St. Louis Shriners Hospitals for Children; Co-Director, Washington University Center of Regenerative Medicine

Dr. Farshid Guilak is the Mildred B. Simon Professor of Orthopaedic Surgery at Washington University, Director of Research for the St. Louis Shriners Hospitals for Children, and co-director of the Washington University Center of Regenerative Medicine. His laboratory is pursuing a multidisciplinary approach for developing new tissue engineering and stem cell-based therapies for musculoskeletal diseases, with a focus on the role of obesity in osteoarthritis. His laboratory has spearheaded the application of genome engineering and synthetic biology to stem cells, in the context of tissue engineering and regenerative medicine. He has published over 380 articles in peer-reviewed journals and has co-edited four books. He was the editor-in-chief of the Journal of Biomechanics for the past 20 years and continues to serve on numerous other journal editorial boards. He has won several national and international awards for his research, including the Kappa Delta Award for orthopaedic research 3 times, as well as 5 separate awards for mentoring. He has also worked extensively in the translation of tissue engineering technologies and he is the Founder of Cytex Therapeutics, a startup company focusing on developing new regenerative medicine therapies for musculoskeletal conditions, and co-founder of several other biotechnology-based startups.